Junera

Sales Rep Portal

Everything you need to sell Junera

Clinical evidence, competitive intelligence, sales scripts, training videos, and downloadable materials — all in one place.

15+
Peer-Reviewed Studies
Published clinical papers
80–100%
Patient Satisfaction
Across multiple studies
48.75%
Dermis Density Increase
Nilforoushzadeh et al., 2023
53.78%
Wrinkle Volume Decrease
Nilforoushzadeh et al., 2023
1
Sessions Needed
Single treatment session
0
Serious Adverse Events
Across all studies

The Competitive Advantage

Single-Session Results

Clinically significant improvement in one treatment — no repeat visits. Results develop over 3–6 months as collagen remodeling occurs.

Measurable Outcomes

48.75% dermis density increase, 53.78% wrinkle volume decrease, and 80–100% patient satisfaction documented across 15+ peer-reviewed studies.

Zero Serious Adverse Events

Confirmed across a systematic review of 31 studies. Real-time thermal monitoring keeps surface temperature below 40°C.

For internal Onyxa Medical sales team use only. Not for distribution to patients or the general public. Individual results may vary. Clinical statistics cited from published peer-reviewed studies. Junera is cleared under FDA 510(k) K212734 for soft tissue surgery and laser-assisted lipolysis.